Alium Group

Alium Group is a specialist pharmaceutical services company that provides global access to medicines through its core business, Alium Medical. The company specializes in the sourcing and distribution of unlicensed medicines (specials), clinical trial supply, and managed access programs. By leveraging an extensive global network, Alium Group helps healthcare professionals and pharmaceutical companies navigate complex regulatory environments to deliver essential treatments to patients. In 2018, the company was acquired by Clinigen Group, integrating its expertise into a broader suite of global medicine management services. The acquisition significantly enhanced Clinigen's clinical trial services and unlicensed medicine capabilities in the UK and internationally.